Table 1.

Main results of the two clinical studies used for this position paper [16, 17].

	Clinical series
Variable	Granell et al. [16]	Ravi et al. [17]
Number of patients	482a	176b
Age (median; years)	69	62
Sex (M/F); %	42/58	56/44
Patients with CPC; n	100	176
Distribution according CPC (n; %)c
1–4%	83 (83%)	54 (31%)
5–20%	12 (12%)	63 (36%)
More than 20%	5 (5%)	59 (34%)
Median overall survival according to CPC; months
0%	47	53
1-4%	50	17
5–20%	6	13
More than 20%	14	13

^aTotally, 382 patients (included in the number in the table) without circulating plasma cells were used as controls.

^bTotally, 9724 patients (not included in the number in the table) diagnosed in the same period without circulating plasma cells at diagnosis were used as controls.

^cConsidering only patients with circulating plasma cells.

CPC circulating plasma cells.